Physician profile
Daniel Schmitt
NPI 1407240062
$125,328.84
in general payments reported to CMS, 2019-2025
10 companies · $60K in 2025
The $60K reported for 2025 was more than what 96% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $942 · 2020: $823 · 2021: $959 · 2022: $14K · 2023: $12K · 2024: $37K · 2025: $60K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $106K · Food and Beverage: $1,690 · Travel and Lodging: $687 · Education: $67.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $106,436.05 |
| Food and Beverage | $1,689.77 |
| Travel and Lodging | $686.81 |
| Education | $67.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgical Planning Associates, INC. | $118,803.43 | 2022-2025 | Hipxpert System, Hipxpert and Hipinsight System |
| Stryker Corporation | $2,684.40 | 2019-2025 | Mako, System 9 Cd Nxt, Insignia |
| Zimmer Biomet Holdings, INC. | $815.61 | 2020-2025 | Oxford, G7, Oxford Partial Knee |
| Depuy Synthes Sales INC. | $758.69 | 2019-2024 | Attune |
| Medical Device Business Services, INC. | $756.33 | 2019-2025 | Attune |
| Microport Orthopedics INC | $686.81 | 2025 | Mpo Medial Pivot Knee |
| Omnilife Science, INC | $358.75 | 2022-2025 | |
| Smith+Nephew, INC. | $284.32 | 2022 | |
| Total Joint Orthopedics, INC. | $139.40 | 2019 | |
| Conformis, INC. | $41.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Schmitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.